Busy time for transactions in BBMC: Amyris, Draths, TetraVitae, and BioAmber do deals

If anyone believed that the bio-based materials industry was slowing down because of the recession, green backlash, or venture capitalists' indifference, November has been a wake-up call. A flurry of major moves has shaken the space:

Amyris bought Draths. Secretive to the end, the deal terms were ...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Solidia raises $78 million and names new CEO – will these developments finally lead to commercialization?

News Commentary | May 06, 2021

Solidia Technologies has a new CEO, Bryan Kalbfleisch, along with $78 million more in funding from Imperative Ventures, Zero Carbon Partners, and Breakthrough Energy Ventures, along with existing investors. The company has a promising technology, but the lack of scale‑up and commercialization ... Not part of subscription

Ginkgo Bioworks to go public via $17.5 billion SPAC deal

News Commentary | May 13, 2021

Backed by Harry Sloan and Jeff Sagansky, this merger with Soaring Eagle Acquisition will give Ginkgo a pre‑money equity valuation of $15 billion, with an additional $2.5 billion for the combined entity – one of the biggest SPAC deals in recent times. This news comes on the heels of Zymergen's IPO ... To read more, click here.

Funding momentum for cell-based meat continues as Aleph Farms raises $105 million Series B

News Commentary | July 08, 2021

L Catterton and DisruptAD, the venture capital arm of ADQ, led this Series B round, with participation from other corporate strategic investors like Thai Union Group, Cargill, and CJ CheilJedang, among others. Aleph Farms will use this funding to scale up cell‑based beef steak production and to ... Not part of subscription